Literature DB >> 28225755

Intragenic DNA methylation prevents spurious transcription initiation.

Francesco Neri1,2, Stefania Rapelli3, Anna Krepelova1,3, Danny Incarnato1, Caterina Parlato1, Giulia Basile1, Mara Maldotti1,3, Francesca Anselmi1,3, Salvatore Oliviero1,3.   

Abstract

In mammals, DNA methylation occurs mainly at CpG dinucleotides. Methylation of the promoter suppresses gene expression, but the functional role of gene-body DNA methylation in highly expressed genes has yet to be clarified. Here we show that, in mouse embryonic stem cells, Dnmt3b-dependent intragenic DNA methylation protects the gene body from spurious RNA polymerase II entry and cryptic transcription initiation. Using different genome-wide approaches, we demonstrate that this Dnmt3b function is dependent on its enzymatic activity and recruitment to the gene body by H3K36me3. Furthermore, the spurious transcripts can either be degraded by the RNA exosome complex or capped, polyadenylated, and delivered to the ribosome to produce aberrant proteins. Elongating RNA polymerase II therefore triggers an epigenetic crosstalk mechanism that involves SetD2, H3K36me3, Dnmt3b and DNA methylation to ensure the fidelity of gene transcription initiation, with implications for intragenic hypomethylation in cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28225755     DOI: 10.1038/nature21373

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  202 in total

1.  A Conformational Switch in the Zinc Finger Protein Kaiso Mediates Differential Readout of Specific and Methylated DNA Sequences.

Authors:  Evgenia N Nikolova; Robyn L Stanfield; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-05-12       Impact factor: 3.162

2.  High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients.

Authors:  Justin Chen; Maria K Haanpää; Joshua J Gruber; Natalie Jäger; James M Ford; Michael P Snyder
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

Review 3.  Mapping chromatin modifications at the single cell level.

Authors:  Connor H Ludwig; Lacramioara Bintu
Journal:  Development       Date:  2019-06-27       Impact factor: 6.868

Review 4.  Protein Interactions at Oxidized 5-Methylcytosine Bases.

Authors:  Gerd P Pfeifer; Piroska E Szabó; Jikui Song
Journal:  J Mol Biol       Date:  2019-08-08       Impact factor: 5.469

Review 5.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.

Authors:  Yiyuan Liu; Minghui Wang; Edoardo M Marcora; Bin Zhang; Alison M Goate
Journal:  Neurosci Lett       Date:  2019-07-24       Impact factor: 3.046

Review 6.  Diverse and dynamic DNA modifications in brain and diseases.

Authors:  Matthew J Armstrong; Yulin Jin; Emily G Allen; Peng Jin
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

Review 7.  Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity.

Authors:  Anthony T Phan; Ananda W Goldrath; Christopher K Glass
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

8.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.

Authors:  Liang Chen; Jia-Yu Chen; Yi-Jou Huang; Ying Gu; Jinsong Qiu; Hao Qian; Changwei Shao; Xuan Zhang; Jing Hu; Hairi Li; Shunmin He; Yu Zhou; Omar Abdel-Wahab; Dong-Er Zhang; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2018-01-27       Impact factor: 17.970

9.  The myonuclear DNA methylome in response to an acute hypertrophic stimulus.

Authors:  Ferdinand Von Walden; Matthew Rea; C Brooks Mobley; Yvonne Fondufe-Mittendorf; John J McCarthy; Charlotte A Peterson; Kevin A Murach
Journal:  Epigenetics       Date:  2020-04-28       Impact factor: 4.528

10.  Transcriptional repression of CDC6 and SLD2 during meiosis is associated with production of short heterogeneous RNA isoforms.

Authors:  David V Phizicky; Stephen P Bell
Journal:  Chromosoma       Date:  2018-10-01       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.